3151 related articles for article (PubMed ID: 7818283)
1. Point mutations and allelic loss in the TP53 locus of cutaneous malignant melanomas.
Weiss J; Cavenee WK; Herbst RA; Jung EG; Arden KC
Arch Dermatol Res; 1994; 286(7):417-9. PubMed ID: 7818283
[No Abstract] [Full Text] [Related]
2. Mutation and expression of TP53 in malignant melanomas.
Weiss J; Heine M; Arden KC; Körner B; Pilch H; Herbst RA; Jung EG
Recent Results Cancer Res; 1995; 139():137-54. PubMed ID: 7597286
[TBL] [Abstract][Full Text] [Related]
3. Mutation and expression of the p53 gene in malignant melanoma cell lines.
Weiss J; Schwechheimer K; Cavenee WK; Herlyn M; Arden KC
Int J Cancer; 1993 Jun; 54(4):693-9. PubMed ID: 8514460
[TBL] [Abstract][Full Text] [Related]
4. Lack of allelic deletion and point mutation as mechanisms of p53 activation in human malignant melanoma.
Castresana JS; Rubio MP; Vázquez JJ; Idoate M; Sober AJ; Seizinger BR; Barnhill RL
Int J Cancer; 1993 Oct; 55(4):562-5. PubMed ID: 8104906
[TBL] [Abstract][Full Text] [Related]
5. p53 mutations in human cutaneous melanoma correlate with sun exposure but are not always involved in melanomagenesis.
Zerp SF; van Elsas A; Peltenburg LT; Schrier PI
Br J Cancer; 1999 Feb; 79(5-6):921-6. PubMed ID: 10070891
[TBL] [Abstract][Full Text] [Related]
6. p53 gene mutation and expression in naevi and melanomas.
Sparrow LE; Soong R; Dawkins HJ; Iacopetta BJ; Heenan PJ
Melanoma Res; 1995 Apr; 5(2):93-100. PubMed ID: 7620345
[TBL] [Abstract][Full Text] [Related]
7. TP53 allele loss, mutations and expression in malignant melanoma.
Flørenes VA; Oyjord T; Holm R; Skrede M; Børresen AL; Nesland JM; Fodstad O
Br J Cancer; 1994 Feb; 69(2):253-9. PubMed ID: 7905277
[TBL] [Abstract][Full Text] [Related]
8. Mutation and expression of the p53 gene in human malignant melanoma.
Albino AP; Vidal MJ; McNutt NS; Shea CR; Prieto VG; Nanus DM; Palmer JM; Hayward NK
Melanoma Res; 1994 Feb; 4(1):35-45. PubMed ID: 8032216
[TBL] [Abstract][Full Text] [Related]
9. Lack of p53 mutations and loss of heterozygosity in non-cultured human melanocytic lesions.
Papp T; Jafari M; Schiffmann D
J Cancer Res Clin Oncol; 1996; 122(9):541-8. PubMed ID: 8781568
[TBL] [Abstract][Full Text] [Related]
10. Deletion mapping of chromosome region 9p21-p22 surrounding the CDKN2 locus in melanoma.
Ohta M; Berd D; Shimizu M; Nagai H; Cotticelli M-G ; Mastrangelo M; Shields JA; Shields CL; Croce CM; Huebner K
Int J Cancer; 1996 Mar; 65(6):762-7. PubMed ID: 8631588
[TBL] [Abstract][Full Text] [Related]
11. Mutations in the TP53 gene in human malignant melanomas derived from sun-exposed skin and unexposed mucosal membranes.
Ragnarsson-Olding BK; Karsberg S; Platz A; Ringborg UK
Melanoma Res; 2002 Oct; 12(5):453-63. PubMed ID: 12394187
[TBL] [Abstract][Full Text] [Related]
12. Frequent TP53 gene alterations (mutation, allelic loss, nuclear accumulation) in primary non-small cell lung cancer.
Shipman R; Schraml P; Colombi M; Raefle G; Dalquen P; Ludwig C
Eur J Cancer; 1996 Feb; 32A(2):335-41. PubMed ID: 8664051
[TBL] [Abstract][Full Text] [Related]
13. Absence of p53 gene mutations in cutaneous melanoma.
Lübbe J; Reichel M; Burg G; Kleihues P
J Invest Dermatol; 1994 May; 102(5):819-21. PubMed ID: 8176269
[TBL] [Abstract][Full Text] [Related]
14. Frequent mutations of the p53 gene in cutaneous melanoma of the nodular type.
Akslen LA; Monstad SE; Larsen B; Straume O; Ogreid D
Int J Cancer; 1998 Feb; 79(1):91-5. PubMed ID: 9495365
[TBL] [Abstract][Full Text] [Related]
15. A constitutional de novo mutation in exon 8 of the p53 gene in a patient with multiple primary malignancies.
Speiser P; Gharehbaghi-Schnell E; Eder S; Haid A; Kovarík J; Nenutil R; Sauter G; Schneeberger CH; Vojtesek B; Wiltschke CH; Zeillinger R
Br J Cancer; 1996 Jul; 74(2):269-73. PubMed ID: 8688334
[TBL] [Abstract][Full Text] [Related]
16. TTC4, a novel candidate tumor suppressor gene at 1p31 is often mutated in malignant melanoma of the skin.
Poetsch M; Dittberner T; Cowell JK; Woenckhaus C
Oncogene; 2000 Nov; 19(50):5817-20. PubMed ID: 11126369
[TBL] [Abstract][Full Text] [Related]
17. Further evidence for ultraviolet light induction of CDKN2 (p16INK4) mutations in sporadic melanoma in vivo.
Herbst RA; Gutzmer R; Matiaske F; Mommert S; Kapp A; Weiss J; Arden KC; Cavenee WK
J Invest Dermatol; 1997 Jun; 108(6):950. PubMed ID: 9182829
[No Abstract] [Full Text] [Related]
18. Frameshift mutations of RIZ, but no point mutations in RIZ1 exons in malignant melanomas with deletions in 1p36.
Poetsch M; Dittberner T; Woenckhaus C
Oncogene; 2002 May; 21(19):3038-42. PubMed ID: 12082534
[TBL] [Abstract][Full Text] [Related]
19. Expression of mutant p53 in melanoma.
Stretch JR; Gatter KC; Ralfkiaer E; Lane DP; Harris AL
Cancer Res; 1991 Nov; 51(21):5976-9. PubMed ID: 1933861
[TBL] [Abstract][Full Text] [Related]
20. Evidence for a gene on 17p13.3, distal to TP53, as a target for allele loss in breast tumors without p53 mutations.
Cornelis RS; van Vliet M; Vos CB; Cleton-Jansen AM; van de Vijver MJ; Peterse JL; Khan PM; Børresen AL; Cornelisse CJ; Devilee P
Cancer Res; 1994 Aug; 54(15):4200-6. PubMed ID: 8033152
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
